Abstract
Natural products from soil-dwelling microorganisms like Pseudomonads are a consistent source of antimicrobial metabolites. This study reports the isolation of Pseudomonas mosselii strain 923 from rice rhizosphere soils, which specifically inhibits the growth of Xanthomonas bacterial pathogens and the fungal pathogen Magnaporthe oryzae. The active compound was identified as pseudoiodinine. Genetic analysis defined its biosynthetic cluster as psdABCDEFG, regulated by GacA and small RNAs rsmY/Z, with CsrA proteins acting as negative regulators. By optimizing media and removing CsrA binding sites, a 22.4-fold increase in production was achieved. Both strain 923 and purified pseudoiodinine effectively control plant diseases in planta without harming the rice host.
Introduction
Rice production is globally threatened by pathogens such as Xanthomonas oryzae (causing bacterial leaf blight and streak) and Magnaporthe oryzae (causing rice blast). While chemical pesticides are common, they pose environmental risks and drive drug resistance. Biocontrol agents—beneficial bacteria that naturally suppress pathogens—offer a sustainable alternative. However, low natural production levels and poorly understood biosynthetic pathways often hinder their application. This research identifies pseudoiodinine from P. mosselii 923 as a potent natural weapon and provides the genetic blueprint to scale its production.
Methods
The study utilized a multi-disciplinary approach combining classical microbiology with modern synthetic biology:
- Screening: 223 bacterial isolates from Chinese rice rhizosphere soil were screened for antagonistic activity.
- Identification: The active compound, pseudoiodinine, was purified via HPLC and characterized using High-Resolution Mass Spectra (HRMS), NMR, and single-crystal X-ray diffraction.
- Genetic Mapping: Transposon mutagenesis and RNA-seq identified the psdABCDEFG biosynthetic cluster and the global regulator gacA.
- Regulatory Analysis: Electrophoretic Mobility Shift Assays (EMSA) and GUS reporter fusions elucidated the GacS/GacA-rsmY/Z-CsrA regulatory cascade.
- Engineering: Production was boosted through media optimization, operon overexpression, and RBS (Ribosome Binding Site) swapping to remove translational repression sites.
Results
Broad-Spectrum Antimicrobial Activity
Pseudoiodinine demonstrated superior potency against a range of pathogens. Its Minimum Inhibitory Concentration (MIC) against rice leaf blight was 0.5 µg/mL, significantly lower than the 1.0 µg/mL required for phenazine-1-carboxylic acid (PCA), a common biopesticide used in China.
Biosynthetic Regulation and Engineering
The researchers discovered that CsrA2 and CsrA3 proteins act as translational repressors by binding to the 5' untranslated region of the psdA mRNA. By "editing" these binding sites out and overexpressing the biosynthetic operon, the team achieved a 22.4-fold increase in pseudoiodinine yield, moving from 1.9 mg/L in the wild-type strain to 42.5 mg/L in the engineered strain.
In Planta Biocontrol Efficacy
Crucially, both the 923 strain and purified pseudoiodinine significantly reduced disease symptoms in rice without affecting the host plant's health. In greenhouse assays, treatment with either the strain or the compound reduced lesion areas by approximately 50% compared to untreated controls.
Discussion
While the 22-fold increase in production is a major step forward, 42.5 mg/L may still require further optimization for industrial-scale viability. Future work should focus on identifying the specific molecular targets of pseudoiodinine within pathogens and assessing its long-term environmental stability and impact on the soil microbiome. Nevertheless, pseudoiodinine represents a promising, eco-friendly candidate for integrated pest management in rice cultivation, offering a "green" alternative to traditional chemical pesticides.
Summary updated